Skip to content
MarketNewsAPI
Product Live news Screener Coverage Pricing
Docs Overview REST API WebSocket API MCP server
Resources Use cases Blog Changelog Status Compare Contact
Log in Get API key Dashboard
CSCO$100.72-2.94(-2.84%)Desktop Virtualization Market Size, Share, Trends, and Growth Forecasts, 2026-2031 | Cloud DaaS and Hybrid Work Propel Market to USD 20.54 Billion as Asia-Pacific Leads Growth9:09:39 AM ETIBM$255.80+1.48(+0.58%)Industrial Edge Computing Market Size, Share, Trends, and Growth Forecasts, 2026-2031 | Edge AI, IIoT, and Private-5G Drive 13.24% CAGR to USD 114.87 Billion9:08:39 AM ETQUBT$6.23-0.20(-3.11%)Next-generation Computing Market Size, Share, Trends, and Growth Forecasts 2026-2031 | AI, Quantum, and Edge Investment Drive 19.02% CAGR to USD 650.48 Billion9:07:40 AM ETKO$96.91+1.03(+1.07%)Digital Transformation (DX) - Market Size, Share, Trends, and Growth Forecasts, 2026-2031 | AI and Cloud Adoption Drive Growth to USD 5.33 Trillion9:05:41 AM ETBNTX$90.84+0.20(+0.22%)Messenger Ribonucleic Acid (mRNA) Manufacturing Service Market Report 2026 | Capitalize on 16.2% CAGR in IVT and LNP with Thermo Fisher, Merck, Lonza and GenScript ProBio9:03:39 AM ETMSFT$555.97+0.17(+0.03%)Green IT Software Market Size, Share, Trends, and Growth Forecasts, 2026-2031 | ESG Mandates and AI Optimization Propel Market to USD 49.35 Billion9:02:40 AM ETTEM$73.32-2.30(-3.04%)Personal Genome Services Market Report 2026: Global Forecast to 2030 | Market to Reach $13.69 Billion by 2030 as Personalized Medicine Adoption Accelerates9:01:40 AM ETVZ$46.61+0.44(+0.95%)Verizon announces cap increases and expiration and results of its tender offers for five series of notes9:00:57 AM ETJPM$357.40+5.18(+1.47%)Chase Travel Unveils 27 Trips to Take in 2027 and Previews Expanded Luxury Vacation Homes Offering9:00:16 AM ETAMGN$483.00+4.52(+0.94%)REPATHA® LOWERS RISK OF HEART ATTACKS BY 20% COMPARED WITH EZETIMIBE IN A LARGE REAL-WORLD STUDY9:00:00 AM ETTM$215.96+16.50(+8.27%)Forterra and May Mobility Advance to Phase III of DIU’s ROADS Challenge, Bringing Autonomous Rides to Soldiers on Military Bases9:00:00 AM ETTXN$302.95-8.65(-2.78%)XGIMI and Kickstarter Present NYC Innovation Showcase Featuring Record-Breaking AURA 3 Series Projector9:00:00 AM ETTM$215.96+16.50(+8.27%)2027 Toyota RAV4 Builds on a Fully Electrified Formula with New Woodland Capability and Expanded Charging Convenience9:00:00 AM ETHD$359.50+4.06(+1.14%)Home Decor Market to Hit USD 955.3 Billion by 2032 Supported by Rising Consumer Interest in Interior Design and Home Aesthetics, Says Mordor Intelligence9:00:00 AM ETASTS$34.40-1.22(-3.43%)SpaceX vs. Rocket Lab vs. AST SpaceMobile: 3 Space Stocks Compared on the Only Numbers That Matter9:00:00 AM ETPLTR$166.17-5.53(-3.22%)AmeriLife and Palantir Announce Enterprise Partnership to Bring AI-Driven Transformation to Insurance and Retirement Distribution9:00:00 AM ETAMAT$351.04-18.19(-4.93%)Lilac Biosciences Names Adriana Coll De Peña, Ph.D., Chief Executive Officer to Bring Fast, Quantitative RNA Measurement to Every Lab9:00:00 AM ETJNJ$279.11+2.73(+0.99%)3 Dependable Dividend Stocks for a $250,000 Passive Income Strategy8:56:52 AM ETDIS$119.98+1.03(+0.87%)137-Room Hilton Garden Inn Lake Buena Vista - Orlando Completes $2.3 Million Renovation8:56:00 AM ETKLAC$143.04-6.61(-4.42%)KLA: Down By 49.3%, But Earnings Are Rising8:53:07 AM ETMSFT$555.97+0.17(+0.03%)Voters Just Made Microsoft's Data Centers More Valuable, a Wall Street Veteran Says8:52:56 AM ETNFLX$67.11+0.72(+1.08%)Bill Ackman Says Long-Term Investors Can Benefit From a Broken Market. Here's the Price I'd Pay for Netflix Stock.8:52:02 AM ETJAN$28.91-1.14(-3.79%)BUZZ-Janus Living falls on upsized $748 mln equity raise8:51:45 AM ETBLK$1,235.00+10.63(+0.87%)The London Company Income Equity Vs. Russell 1000 Q3 2026 Commentary8:50:00 AM ET

HCWB · NASDAQ

HCW Biologics Inc.

$1.09 +0.01 (+0.93%)

Company overview

HCW Biologics Inc. is a preclinical stage biopharmaceutical company focused on discovering and developing novel immunotherapies for chronic, low-grade inflammation and age-related diseases. The company's lead product candidates include HCW9218, an injectable immunotherapeutic for patients with pancreatic, ovarian, breast, prostate, and colorectal cancers, as well as pulmonary fibrosis; and HCW9302 for autoimmune diseases such as alopecia areata and metabolic diseases. It also develops HCW9201, a cell-based therapy currently in Phase II clinical trials for the treatment of patients with relapsed or refractory acute myeloid leukemia; and HCW9206 for the treatment of acute myeloid leukemia. The company was incorporated in 2018 and is headquartered in Miramar, Florida.

Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Market cap
$378,929
Employees
36
Headquarters
Miramar, FL
Website
hcwbiologics.com
CEO
Hing C. Wong
Listed
July 20, 2021
P/E
-0.13
Dividend yield
0.00%

Company financials

Revenue
$6.6M
Gross profit
$6.5M
Operating income
-$6.5M
EBITDA
-$1.1M
Net income
-$1.6M
EPS
-$8.49
Total assets
$27.3M
Total debt
$6.6M
Gross margin
99.24%
Net margin
-24.73%
Earnings yield
-744.74%

Revenue segmentation

By product

No annual segmentation.

By region

No geographic segmentation.

Price chart

0.176.3412.5118.6824.85
HCWB 1D NASDAQ O1.10H1.15L1.08C1.08-0.07 (-6.09%)Vol16.02K

News

15-min delaySigned-out view is delayed 15 minutes. Log in on Pro for the live news desk.

Start 7-day free trial See live plans
Source
Date
Type
View
Ticker Type Headline Source Published
HCWBHCW Biologics Inc. Press release HCW Biologics Secures up to $10.0 Million in Cash Through Debt Financing GlobeNewswire
HCWBHCW Biologics Inc. Press release HCW Biologics Announces Pricing of $1.5 Million Private Placement GlobeNewswire
HCWBHCW Biologics Inc. Press release HCW Biologics Entered an Exclusive Distribution Agreement with Akron Biotech to Commercialize HCW11-006 as Reagent Used to Support Production of Highly Functional Human CAR-T Cells GlobeNewswire
HCWBHCW Biologics Inc. Press release HCW Biologics Strengthens U.S. Patent Estate for Its Lead Clinical-Stage Immunotherapeutic HCW9302 as Alopecia Areata Treatment GlobeNewswire
HCWBHCW Biologics Inc. Press release HCW Biologics' TGF-β Trap and IL-15 Fusion is a Novel Moiety to Enhance Immunotherapeutic Activity against Diseased Cells GlobeNewswire
HCWBHCW Biologics Inc. Press release HCW Biologics Reports Second Quarter 2026 Business and Clinical Development Highlights and Financial Results GlobeNewswire
HCWBHCW Biologics Inc. Press release HCW Biologics Reaches Milestones for Its Proprietary Tetravalent Second-Generation T-Cell Engager Program On Track To Initiate Clinical Trials in First Half 2027 GlobeNewswire
HCWBHCW Biologics Inc. Press release HCW Biologics Exercised Option to Regain Full Rights for Two Commercial-Ready Reagents from Wugen GlobeNewswire
HCWBHCW Biologics Inc. Press release E.F. Hutton & Co. Serves as Sole Placement Agent on HCW Biologics Inc. $4.0 Million Private Placement GlobeNewswire
HCWBHCW Biologics Inc. Stock news Crude Oil Surges 3%; RBC Bearings Earnings Top Views Benzinga
HCWBHCW Biologics Inc. Stock news HCW Biologics (HCWB) Stock Is Trending Overnight — Here's Why It Moved Over 122% In After-Hours Session Benzinga
HCWBHCW Biologics Inc. Press release HCW Biologics Reports First Quarter 2026 Business Highlights and Financial Results GlobeNewswire
HCWBHCW Biologics Inc. Press release HCW Biologics Discovers that HCW11-040 Prevents Bronchopulmonary Dysplasia (BPD) During IND-Enabling Studies GlobeNewswire
HCWBHCW Biologics Inc. Press release HCW Biologics Announces Adjournment of Special Meeting of Stockholders Due to Lack of Quorum GlobeNewswire
HCWBHCW Biologics Inc. Press release HCW Biologics Delivers a Major Update for its T-Cell Engager Program Revealing Mechanism of Action and Validating Tissue Factor as Target for Treatment of Solid Tumors GlobeNewswire
HCWBHCW Biologics Inc. Press release HCW Biologics Reports Fourth Quarter 2025 and Fiscal Year 2025 Business Highlights and Financial Results GlobeNewswire
HCWBHCW Biologics Inc. Stock news HCW Biologics (HCWB) Projected to Post Earnings on Wednesday Defense World
HCWBHCW Biologics Inc. Press release HCW Biologics Closes Exclusive Worldwide License for HCW11-006 – A High Potential Fusion Immunotherapeutic GlobeNewswire
HCWBHCW Biologics Inc. Press release HCW Biologics Announces Positive Research Results for CAR-T Cell Therapy Manufactured Utilizing Its Commercial-Ready Proprietary Compound, HCW9206, Published in Science Advances GlobeNewswire
HCWBHCW Biologics Inc. Press release HCW Biologics Regains Compliance with All Continued Listing Rules for Nasdaq Per Nasdaq Determination Letter GlobeNewswire
See more
FAQ

Questions about HCW Biologics Inc.

What does HCW Biologics Inc. do?
HCW Biologics Inc. is a preclinical stage biopharmaceutical company focused on discovering and developing novel immunotherapies for chronic, low-grade inflammation and age-related diseases. The company's lead product candidates include HCW9218, an injectable immunotherapeutic for patients with pancreatic, ovarian, breast, prostate, and colorectal cancers, as well as pulmonary fibrosis; and HCW9302 for autoimmune diseases such as alopecia areata and metabolic diseases. It also develops HCW9201, a cell-based therapy currently in Phase II clinical trials for the treatment of patients with relapsed or refractory acute myeloid leukemia; and HCW9206 for the treatment of acute myeloid leukemia. The company was incorporated in 2018 and is headquartered in Miramar, Florida.
What is HCWB's market cap?
HCW Biologics Inc. (HCWB) is a listed stock with a live quote. The latest market cap on this page is $378,929.
Where is HCW Biologics Inc. headquartered?
HCW Biologics Inc. is headquartered in Miramar, FL.
How do I get HCWB news from the API?
Call GET /v1/news?tickers=HCWB. Add type=news, type=press_release, or type=legal to take one feed. Pro keys search articles since 2020 in real time. Free keys are delayed 15 minutes and return the last year. Signed-out visitors and Free accounts see that same year on this page. Pro sees articles since 2020.
How far back does HCWB news go?
Signed-out visitors and Free accounts see the last year of stock news, press releases, and legal notices for HCWB, 15 minutes behind, and each headline links to the publisher. Pro, including the 7-day trial, sees articles since 2020 as headlines are ingested. A Free API key returns the last year. Pro keys search articles since 2020.
Is the HCWB price on this page from the API?
The price and daily change update during the US session for every visitor. That quote is context on this page. It is not part of the news API. The chart is one candle per session from the start of 2020. 1W, 1M, and 1Y group those sessions.
Can I use the Pro plan commercially?
No. The Pro plan cannot be used for commercial work. A product you sell, work you do for a client, or redistribution of the feed needs a custom plan and a license. Email [email protected].

Real-time stock news for $15 a month.

Start a 7-day Pro trial. A card is required. REST, WebSocket, and MCP are included, with 250 REST requests a day, 1 WebSocket connection, 5 requests per second, and 2,500 WebSocket messages a day. You won't be charged during the trial. Unless you cancel, the card is billed for Pro when it ends.

Start 7-day free trial Read the docs